UPDATE: Wunderlich Raises PT on Symmetry Medical, Revenue Growth Expected

In a report published Friday, Wunderlich Securities analyst James Terwilliger reiterated a Buy rating on Symmetry Medical, Inc. (NYSE: SMA ), raising their price target from $10.00 to $11.00. According to the report, “We are raising our 2014 estimates and price target for Symmetry Medical, Inc. (SMA). We are raising